Cantel Medical (CMD) Tops Q3 EPS by 4c

Cantel Medical (NYSE: CMD) reported Q3 EPS of $0.16, $0.04 better than the analyst estimate of $0.12. Revenue for the quarter came in at $236.9 million versus the consensus estimate of $235.41 million.

For earnings history and earnings-related data on Cantel Medical (CMD) click here.

You May Also Be Interested In

• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
• H.B. Fuller board rejects Ancora's $1.1B-$1.2B BAS unit bid
• Bernstein SocGen on StandardAero Inc (SARO): ' Solid revenues, but short-term margin issues'